In Vivo Glx Measurements From GABA‐Edited HERMES at 3 T Are Not Consistent With Those From Short‐TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups
NMR in Biomedicine · 2026
DOI: 10.1002/nbm.70171 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, 2026. Verfasst von Alice R Thomson und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: gamma-Aminobutyric Acid, Brain, Glutamic Acid, Glutamine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking, Medical Research Council, Horizon2020.
Abstract (Originalsprache)
1H‐Magnetic resonance spectroscopy (1H‐MRS) is a noninvasive technique for quantifying brain metabolites, including glutamate, glutathione (GSH), and γ‐aminobutyric acid (GABA), which are essential for brain function and implicated in various neurodevelopmental conditions. As such, 1H‐MRS methods that enable reliable and accurate measurement of these metabolites are of considerable clinical value. Hadamard Encoding and Reconstruction of MEGA‐Edited Spectroscopy (HERMES; echo time [TE] = 80 ms) is a spectral editing technique that allows for the simultaneous quantification of GABA and GSH, using subtraction approaches to resolve these metabolites in a difference spectrum. Additionally, glutamate plus glutamine resonances (Glx) can be resolved either from the HERMES GABA‐edited difference spectrum (GABA‐DIFF) or from the sum of all HERMES transients (SUM spectrum). However, the reliability of 80‐ms HERMES for quantification of Glx has not been systematically assessed. Here, we evaluate the agreement between Glx obtained from HERMES GABA‐DIFF and SUM spectra with Glx derived from short‐TE PRESS (TE = 35 ms), which is conventionally used for Glx estimation and has demonstrated reproducibility. Data were acquired from 139 participants across two brain regions (ACC and Thalamus voxels), three scanners, two diagnostic groups (autism and neurotypical development) and two age groups (adolescent/adult and preschooler). Comparisons were made using both creatine‐scaled and tissue‐corrected Glx estimates. Our findings demonstrate significant systematic and proportional bias between Glx estimates from HERMES (SUM and GABA‐DIFF) and short‐TE PRESS, consistent across scanners, voxels, age groups and diagnostic categories. These findings indicate that Glx estimates derived from HERMES are not directly comparable to those from short‐TE PRESS, and this discrepancy is consistent across a multisite study setting. This underscores the importance of sequence selection and careful methodological consideration when integrating and interpreting data from 1H‐MRS across different acquisition protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
- MRC Centre for Neurodevelopmental Disorders, King's College London, London, UK.
- Autism Research Centre, University of Cambridge, Cambridge, UK.
- Research in Developmental Diversity Lab, Department of Experimental-Clinical and Health Psychology, Ghent University, Belgium.
- Development and Neurodiversity Lab, Department of Psychology, Uppsala University, Uppsala, Sweden.
- Department of Child and Adolescent Psychiatry, King's College London, London, UK.
ORCID-Profile: Beth Oakley, Ellen Demurie, Giorgia Bussu, Julia Koziel, Tony Charman, Tomoki Arichi
Förderung
- Innovative Medicines Initiative 2 Joint Undertaking
- Medical Research Council
- Horizon2020
Zitieren
APA
Thomson, A. R., Hollestein, V., Goodwin, A., Fritz, A., Oakley, B., Murphy, D., Bullock, E., Demurie, E., Loth, E., Bussu, G., Roeyers, H., Yorke, I., Buitelaar, J. K., Koziel, J., Colomar, L., Krol, M. A., Bowdler, M., Herregods, N., Aggensteiner, P., …, & Puts, N. A. (2026). In Vivo Glx Measurements From GABA‐Edited HERMES at 3 T Are Not Consistent With Those From Short‐TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups. NMR in Biomedicine. https://doi.org/10.1002/nbm.70171
Vancouver
Thomson AR, Hollestein V, Goodwin A, Fritz A, Oakley B, Murphy D, et al. In Vivo Glx Measurements From GABA‐Edited HERMES at 3 T Are Not Consistent With Those From Short‐TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups. NMR in Biomedicine. 2026. doi:10.1002/nbm.70171
BibTeX
@article{Thomson2026,
author = {Thomson, Alice R and Hollestein, Viola and Goodwin, Amy and Fritz, Anne and Oakley, Beth and Murphy, Declan and Bullock, Edward and Demurie, Ellen and Loth, Eva and Bussu, Giorgia and Roeyers, Herbert and Yorke, Isabel and Buitelaar, Jan K and Koziel, Julia and Colomar, Laura and Krol, Manon A and Bowdler, Matthew and Herregods, Nele and Aggensteiner, Pascal and Pullens, Pim and Holt, Rosemary and Falck-Ytter, Terje and Charman, Tony and Arichi, Tomoki and Puts, Nicolaas A},
title = {In Vivo Glx Measurements From GABA‐Edited HERMES at 3 T Are Not Consistent With Those From Short‐TE PRESS Across Scanners, Brain Regions, Diagnostic and Age Groups},
journal = {NMR in Biomedicine},
year = {2026},
doi = {10.1002/nbm.70171}
}
EUVIMED